MTOR and hepatocellular carcinoma: Compared with that of the control, the phosphorylation level of mTOR and the expression of p-4E-BP and SOX2 all decreased in HCC cells treated with rapamycin (Figure 3B), and such results are similar to the changes of stemness characteristic under mTOR-specific inhibition (Figure 2).